DENTSPLY SIRONA Inc (NASDAQ:XRAY) has received an average rating of “Hold” from the eighteen analysts that are currently covering the stock, MarketBeat reports. Two analysts have rated the stock with a sell recommendation, six have given a hold recommendation and nine have assigned a buy recommendation to the company. The average 1-year price objective among brokers that have issued a report on the stock in the last year is $61.00.
XRAY has been the topic of a number of recent analyst reports. Morgan Stanley cut their target price on DENTSPLY SIRONA from $65.00 to $54.00 and set an “overweight” rating on the stock in a research report on Thursday. HC Wainwright cut their target price on DENTSPLY SIRONA from $63.00 to $52.00 and set a “neutral” rating on the stock in a research report on Tuesday, May 8th. ValuEngine lowered DENTSPLY SIRONA from a “sell” rating to a “strong sell” rating in a research report on Tuesday, May 22nd. Credit Suisse Group cut their target price on DENTSPLY SIRONA from $73.00 to $69.00 and set an “outperform” rating on the stock in a research report on Friday, March 2nd. Finally, BidaskClub lowered DENTSPLY SIRONA from a “sell” rating to a “strong sell” rating in a research report on Wednesday, February 28th.
In related news, Director Michael J. Coleman sold 6,038 shares of the company’s stock in a transaction on Friday, June 1st. The stock was sold at an average price of $43.97, for a total transaction of $265,490.86. Following the transaction, the director now directly owns 26,960 shares of the company’s stock, valued at $1,185,431.20. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Donald M. Jr. Casey purchased 22,500 shares of the company’s stock in a transaction that occurred on Wednesday, May 9th. The shares were acquired at an average cost of $44.52 per share, for a total transaction of $1,001,700.00. Following the completion of the transaction, the chief executive officer now directly owns 92,408 shares of the company’s stock, valued at approximately $4,114,004.16. The disclosure for this purchase can be found here. Insiders have sold 7,856 shares of company stock worth $349,153 over the last three months. 1.93% of the stock is owned by insiders.
Shares of XRAY traded up $0.38 during midday trading on Friday, reaching $44.89. The stock had a trading volume of 3,905,700 shares, compared to its average volume of 2,503,673. DENTSPLY SIRONA has a 52 week low of $41.64 and a 52 week high of $68.98. The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.46 and a current ratio of 2.23. The company has a market capitalization of $9.87 billion, a PE ratio of 16.88, a P/E/G ratio of 2.24 and a beta of 1.23.
DENTSPLY SIRONA (NASDAQ:XRAY) last announced its earnings results on Sunday, May 6th. The medical instruments supplier reported $0.45 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.42 by $0.03. The company had revenue of $956.10 million for the quarter, compared to analyst estimates of $942.20 million. DENTSPLY SIRONA had a positive return on equity of 8.63% and a negative net margin of 38.32%. DENTSPLY SIRONA’s revenue for the quarter was up 6.2% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.49 earnings per share. equities research analysts forecast that DENTSPLY SIRONA will post 2.58 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, July 13th. Investors of record on Friday, June 29th will be given a dividend of $0.0875 per share. This represents a $0.35 annualized dividend and a yield of 0.78%. The ex-dividend date of this dividend is Thursday, June 28th. DENTSPLY SIRONA’s payout ratio is 13.16%.
About DENTSPLY SIRONA
DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.